查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1125953

胰岛素帮浦的全球市场 (2022年-2027年):用户、产业趋势、占有率、成长率、见解、COVID-19影响、企业分析

Global Insulin Pump Market, Users, Global Forecast 2022-2027, Industry Trends, Share, Growth, Insight, Impact of COVID-19, Company Analysis
出版日期: | 出版商: Renub Research | 英文 440 Pages | 商品交期: 最快1-2个工作天内

价格

全球胰岛素帮浦的市场规模从2021年到2027年以5.20％的年复合成长率发展，2027年成长到209亿1,000万美元的规模。

糖尿病的盛行率上升，及健康意识显着提高，糖尿病也可能导致肾功能衰竭，中风，麻痹，失明等其他慢性疾病，製造商日益着重开发胰岛素帮浦等灵活性和经济性高的技术。还有由于开发非常正确的葡萄糖感测器和血液监控系统，对有效率的胰岛素帮浦的需求也高涨。再加上最近的市场扩大，平均每人的医疗支出增加和提高胰岛素帮浦功能的R&D增加等要素也有帮助。

本报告提供全球胰岛素帮浦的市场调查，市场概要，市场成长的影响因素的分析，主要产品的差异化点，市场规模 (金额、数量) 的变化、预测，各主要国家的详细分析，主要企业简介等彙整资讯。

目录

第1章 简介

第2章 调查手法

第3章 摘要整理

第4章 市场动态

  • 促进因素
  • 课题

第5章 全球胰岛素帮浦市场分析

  • 市场
  • 用户

第6章 全球胰岛素帮浦市场分析 (数量、金额)

  • 国家
  • 用户占有率

第7章 患者及HCP的训练模式:Medtronic、Insulet Corp、Tandem Diabetes Care

  • Medtronic
  • Insulet Corp
  • Tandem Diabetes Care

第8章 在世界可取得的胰岛素帮浦产品的差异化点

  • Medtronic 530G with Enlite
  • InsuletOmniPod
  • Tandem t:slim
  • Roche Accu-Chek Combo

第9章 美国

  • 糖尿病人口
    • 第一型
    • 第2型
  • 胰岛素帮浦市场分析
    • 用户数
    • 市场规模
  • 偿付政策

第10章 英国

  • 糖尿病人口
    • 第一型
    • 第2型
  • 胰岛素帮浦市场分析
    • 用户数
    • 市场规模
  • 偿付政策

第11章 以色列

  • 糖尿病人口
    • 第一型
    • 第2型
  • 胰岛素帮浦市场分析
    • 用户数
    • 市场规模
  • 偿付政策

第12章 德国

  • 糖尿病人口
    • 第一型
    • 第2型
  • 胰岛素帮浦市场分析
    • 用户数
    • 市场规模
  • 偿付政策

第13章 荷兰

  • 糖尿病人口
    • 第一型
    • 第2型
  • 胰岛素帮浦市场分析
    • 用户数
    • 市场规模
  • 偿付政策

第14章 瑞典

  • 糖尿病人口
    • 第一型
    • 第2型
  • 胰岛素帮浦市场分析
    • 用户数
    • 市场规模
  • 偿付政策

第15章 法国

  • 糖尿病人口
    • 第一型
    • 第2型
  • 胰岛素帮浦市场分析
    • 用户数
    • 市场规模
  • 偿付政策

第16章 瑞士

  • 糖尿病人口
    • 第一型
    • 第2型
  • 胰岛素帮浦市场分析
    • 用户数
    • 市场规模
  • 偿付政策

第17章 澳洲

  • 糖尿病人口
    • 第一型
    • 第2型
  • 胰岛素帮浦市场分析
    • 用户数
    • 市场规模
  • 偿付政策

第18章 日本

  • 糖尿病人口
    • 第一型
    • 第2型
  • 胰岛素帮浦市场分析
    • 用户数
    • 市场规模
  • 偿付政策

第19章 加拿大

  • 糖尿病人口
    • 第一型
    • 第2型
  • 胰岛素帮浦市场分析
    • 用户数
    • 市场规模
  • 偿付政策

第20章 科威特

  • 糖尿病人口
    • 第一型
    • 第2型
  • 胰岛素帮浦市场分析
    • 用户数
    • 市场规模
  • 偿付政策

第21章 沙乌地阿拉伯

  • 糖尿病人口
    • 第一型
    • 第2型
  • 胰岛素帮浦市场分析
    • 用户数
    • 市场规模
  • 偿付政策

第22章 义大利

  • 糖尿病人口
    • 第一型
    • 第2型
  • 胰岛素帮浦市场分析
    • 用户数
    • 市场规模
  • 偿付政策

第23章 西班牙

  • 糖尿病人口
    • 第一型
    • 第2型
  • 胰岛素帮浦市场分析
    • 用户数
    • 市场规模
  • 偿付政策

第24章 企业分析

  • Medtronic
  • Insulet Corporation
  • Tandem Diabetes Care
  • Roche

According to Renub Research, Global Insulin Pump Market is estimated to reach US$ 20.91 Billion by 2027. Insulin pumps are compact electronic medical devices that can be fastened to a belt, hidden in a pocket, or worn under clothing. Besides, to regulate the rise in blood glucose levels, the pump delivers controlled quantities of insulin into the body at regular intervals, based on the consumer's basal and bolus rates. Furthermore, it works with a needle and a flexible catheter to inject insulin straight into the fatty tissue, subsequently taped and fastened. In addition, insulin pumps help people with type 1 and type 2 diabetes by giving them more food options and eating schedule flexibility and reducing the number of injections they need.

Global Insulin Pump Market Size Is Expanding with a CAGR Of 5.20% During 2021-2027:

The rising prevalence of diabetes and increased health awareness have been prevalent. Furthermore, because diabetes can lead to other chronic illnesses, including kidney failure, stroke, paralysis, and blindness, manufacturers focus more on developing adaptable and economical technologies like insulin pumps. The demand for efficient insulin pumps has also increased due to the development of very accurate glucose sensors and blood monitoring systems. Furthermore, recent market expansion has been aided by factors such as rising per capita healthcare spending and increased research and development for improving the functionality of insulin pumps.

COVID-19 Impact Analysis on Global Insulin Pump Industry:

According to the IDF, diabetic people were more likely to get COVID-19 disease and experience severe symptoms. As a result, during the COVID-19 pandemic, demand for insulin pumps for at-home use skyrocketed. As a result of the epidemic, the homecare insulin pump business exploded worldwide. Moreover, demand for automated and efficient insulin pumps skyrocketed during the epidemic. Moreover, as per our analysis, Global Insulin Pump Market was US$ 15.43 Billion in 2021.

Segment Analysis in Global Insulin Pump Market:

In our report, the Global Global Insulin Pump Market is studied for the market in the United States, United Kingdom, Israel, Germany, Netherlands, Sweden, France, Switzerland, Australia, Japan, Canada, Kuwait, Saudi Arabia, and Italy and Spain. Further, the market in detail is categorized based on Diabetes Population (Type 1 and Type 2), Insulin Pump Market Analysis (Insulin Pump User (Type 1 and Type 2) & Insulin Pump Market (Type 1 and Type 2)), and Reimbursement Policies on Insulin Pump.

Competitive Landscape:

The Global Insulin Pump Market is highly competitive, competing with only a few companies. Medtronic, Insulet Corporation, Tandem Diabetes Care, and Roche are the critical players profiled in our analysis. These companies control a large percentage of the worldwide market. In addition, they are constantly expanding into new markets to generate new revenue streams and enhance old ones. The acts of these market participants will create a competitive environment, forcing businesses to experiment with the latest technology to keep their products unique. Companies are also collaborating to expand their technological understanding and reduce the time it takes to develop a product.

Renub Research latest report "Global Insulin Pump Market, Global Forecast, By Differentiation Points, Products (Medtronic 530G with Enlite, InsuletOmniPod, Tandem t:slim and Roche Accu-Chek Combo), By Countries (United States, United Kingdom, Israel, Germany, Netherlands, Sweden, France, Switzerland, Australia, Japan, Canada, Kuwait, Saudi Arabia, Italy and Spain), Country Insights (Diabetes Population (Type 1 and Type 2), Insulin Pump Market Analysis (Insulin Pump User (Type 1 and Type 2) & Insulin Pump Market (Type 1 and Type 2)) and Reimbursement Policies on Insulin Pump), Companies (Medtronic, Insulet Corporation, Tandem Diabetes Care and Roche)" provides a detailed analysis of Global Insulin Pump Industry.

The above-mentioned countries have been covered from 3 viewpoints:

1. Diabetes Population

  • Type 1
  • Type 2

2. Insulin Pump Analysis

  • Insulin Pump User (Type 1 and Type 2)
  • Insulin Pump Market (Type 1 and Type 2)

3. Reimbursement Policies on Insulin Pump

Countries - Insulin Pump Market & Users, Diabetes Type 1 & 2 Population of all the 15 Countries Covered in the Report

1. United States

2. United Kingdom

3. Israel

4. Germany

5. Netherlands

6. Sweden

7. France

8. Switzerland

9. Australia

10. Japan

11. Canada

12. Kuwait

13. Saudi Arabia

14. Italy

15. Spain

Differentiation Points, Products Available Worldwide have been covered from 4 viewpoints:

1. Medtronic 530G with Enlite

2. InsuletOmniPod

3. Tandem t:slim

4. Roche Accu-Chek Combo

Company Insights:

  • Overview
  • Recent Development
  • Revenue

Companies Covered:

1. Medtronic

2. Insulet Corporation

3. Tandem Diabetes Care

4. Roche

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Global Insulin Pump Analysis

  • 5.1 Market
  • 5.2 User

6. Global Insulin Pump Market & Volume Share Analysis

  • 6.1 Country
  • 6.2 User Share

7. Training Model for Patients & HCP - of Medtronic, Insulet Corp & Tandem Diabetes Care

  • 7.1 Medtronic
    • 7.1.1 Training Guidelines for Insulin Pump Therapy to New Patients
    • 7.1.2 Training Model for HCP (HealthCare Professional)
  • 7.2 Insulet Corporation
    • 7.2.1 Training Structure for New Patients - Insulet Corporation
  • 7.3 Tandem Diabetes Care

8. Differentiation Points of Insulin Pump Products Available Worldwide

  • 8.1 Medtronic 530G with Enlite
  • 8.2 InsuletOmniPod
  • 8.3 Tandem t:slim
  • 8.4 Roche Accu-Chek Combo

9. United States

  • 9.1 Diabetes Population
    • 9.1.1 Type 1
    • 9.1.2 Type 2
  • 9.2 United States - Insulin Pump Market Analysis
    • 9.2.1 Insulin Pump User
      • 9.2.1.1 Type 1
      • 9.2.1.2 Type 2
    • 9.2.2 Insulin Pump Market
      • 9.2.2.1 Type 1
      • 9.2.2.2 Type 2
  • 9.3 Reimbursement Policies on Insulin Pump

10. United Kingdom

  • 10.1 Diabetes Population
    • 10.1.1 Type 1
    • 10.1.2 Type 2
  • 10.2 Insulin Pump Analysis
    • 10.2.1 Insulin Pump Users
      • 10.2.1.1 Type 1
      • 10.2.1.2 Type 2
    • 10.2.2 Insulin Pump Market
      • 10.2.2.1 Type 1
      • 10.2.2.2 Type 2
  • 10.3 Reimbursement Policies on Insulin Pump

11. Israel

  • 11.1 Diabetes Population
    • 11.1.1 Type 1
    • 11.1.2 Type 2
  • 11.2 Insulin Pump Analysis
    • 11.2.1 Insulin Pump Users
      • 11.2.1.1 Type 1
      • 11.2.1.2 Type 2
    • 11.2.2 Insulin Pump Market
      • 11.2.2.1 Type 1
      • 11.2.2.2 Type 2
  • 11.3 Reimbursement Policies on Insulin Pump

12. Germany

  • 12.1 Diabetes Population
    • 12.1.1 Type 1
    • 12.1.2 Type 2
  • 12.2 Insulin Pump Analysis
    • 12.2.1 Insulin Pump Users
      • 12.2.1.1 Type 1
      • 12.2.1.2 Type 2
    • 12.2.2 Insulin Pump Market
      • 12.2.2.1 Type 1
      • 12.2.2.2 Type 2
  • 12.3 Reimbursement Policies on Insulin Pump

13. Netherlands

  • 13.1 Diabetes Population
    • 13.1.1 Type 1
    • 13.1.2 Type 2
  • 13.2 Insulin Pump Analysis
    • 13.2.1 Insulin Pump Users
      • 13.2.1.1 Type 1
      • 13.2.1.2 Type 2
    • 13.2.2 Insulin Pump Market
      • 13.2.2.1 Type 1
      • 13.2.2.2 Type 2
  • 13.3 Reimbursement Policies on Insulin Pump

14. Sweden

  • 14.1 Diabetes Population
    • 14.1.1 Type 1
    • 14.1.2 Type 2
  • 14.2 Insulin Pump Analysis
    • 14.2.1 Insulin Pump Users
      • 14.2.1.1 Type 1
      • 14.2.1.2 Type 2
    • 14.2.2 Insulin Pump Market
      • 14.2.2.1 Type 1
      • 14.2.2.2 Type 2
  • 14.3 Reimbursement Policies on Insulin Pump

15. France

  • 15.1 Diabetes Population
    • 15.1.1 Type 1
    • 15.1.2 Type 2
  • 15.2 Insulin Pump Analysis
    • 15.2.1 Insulin Pump Users
      • 15.2.1.1 Type 1
      • 15.2.1.2 Type 2
    • 15.2.2 Insulin Pump Market
      • 15.2.2.1 Type 1
      • 15.2.2.2 Type 2
  • 15.3 Reimbursement Policies on Insulin Pump

16. Switzerland

  • 16.1 Diabetes Population
    • 16.1.1 Type 1
    • 16.1.2 Type 2
  • 16.2 Insulin Pump Analysis
    • 16.2.1 Insulin Pump Users
      • 16.2.1.1 Type 1
      • 16.2.1.2 Type 2
    • 16.2.2 Switzerland Insulin Pump Market
      • 16.2.2.1 Type 1
      • 16.2.2.2 Type 2
  • 16.3 Reimbursement Policies on Insulin Pump

17. Australia

  • 17.1 Diabetes Population
    • 17.1.1 Type 1
    • 17.1.2 Type 2
  • 17.2 Insulin Pump Analysis
    • 17.2.1 Insulin Pump Users
      • 17.2.1.1 Type 1
      • 17.2.1.2 Type 2
    • 17.2.2 Insulin Pump Market
      • 17.2.2.1 Type 1
      • 17.2.2.2 Type 2
  • 17.3 Reimbursement Policies on Insulin Pump

18. Japan

  • 18.1 Diabetes Population
    • 18.1.1 Type 1
    • 18.1.2 Type 2
  • 18.2 Insulin Pump Analysis
    • 18.2.1 Insulin Pump Users
      • 18.2.1.1 Type 1
      • 18.2.1.2 Type 2
    • 18.2.2 Insulin Pump Market
      • 18.2.2.1 Type 1
      • 18.2.2.2 Type 2
  • 18.3 Reimbursement Policies on Insulin Pump

19. Canada

  • 19.1 Diabetes Population
    • 19.1.1 Type 1
    • 19.1.2 Type 2
  • 19.2 Insulin Pump Analysis
    • 19.2.1 Insulin Pump Users
      • 19.2.1.1 Type 1
      • 19.2.1.2 Type 2
    • 19.2.2 Insulin Pump Market
      • 19.2.2.1 Type 1
      • 19.2.2.2 Type 2
  • 19.3 Reimbursement Policies on Insulin Pump

20. Kuwait

  • 20.1 Diabetes Population
    • 20.1.1 Type 1
    • 20.1.2 Type 2
  • 20.2 Insulin Pump Analysis
    • 20.2.1 Insulin Pump Users
      • 20.2.1.1 Type 1
      • 20.2.1.2 Type 2
    • 20.2.2 Insulin Pump Market
      • 20.2.2.1 Type 1
      • 20.2.2.2 Type 2
  • 20.3 Reimbursement Policies on Insulin Pump

21. Saudi Arabia

  • 21.1 Diabetes Population
    • 21.1.1 Type 1
    • 21.1.2 Type 2
  • 21.2 Insulin Pump Analysis
    • 21.2.1 Insulin Pump Users
      • 21.2.1.1 Type 1
      • 21.2.1.2 Type 2
    • 21.2.2 Insulin Pump Market
      • 21.2.2.1 Type 1
      • 21.2.2.2 Type 2
  • 21.3 Reimbursement Policies on Insulin Pump

22. Italy

  • 22.1 Diabetes Population
    • 22.1.1 Type 1
    • 22.1.2 Type 2
  • 22.2 Insulin Pump Analysis
    • 22.2.1 Insulin Pump Users
      • 22.2.1.1 Type 1
      • 22.2.1.2 Type 2
    • 22.2.2 Insulin Pump Market
      • 22.2.2.1 Type 1
      • 22.2.2.2 Type 2
  • 22.3 Reimbursement Policies on Insulin Pump

23. Spain

  • 23.1 Diabetes Population
    • 23.1.1 Type 1
    • 23.1.2 Type 2
  • 23.2 Insulin Pump Analysis
    • 23.2.1 Insulin Pump Users
      • 23.2.1.1 Type 1
      • 23.2.1.2 Type 2
    • 23.2.2 Insulin Pump Market
      • 23.2.2.1 Type 1
      • 23.2.2.2 Type 2
  • 23.3 Reimbursement Policies on Insulin Pump

24. Company Analysis

  • 24.1 Medtronic
    • 24.1.1 Overview
    • 24.1.2 Recent Development
    • 24.1.3 Revenue
  • 24.2 Insulet Corporation
    • 24.2.1 Overview
    • 24.2.2 Recent Development
    • 24.2.3 Revenue
  • 24.3 Tandem Diabetes Care
    • 24.3.1 Overview
    • 24.3.2 Recent Development
    • 24.3.3 Revenue
  • 24.4 Roche
    • 24.4.1 Overview
    • 24.4.2 Recent Development
    • 24.4.3 Revenue

List of Figures

  • Figure-01: Global - Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-02: Global - Forecast for Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-03: Global - Insulin Pump User (Thousand), 2017 - 2021
  • Figure-04: Global - Forecast for Insulin Pump User (Thousand), 2022 - 2027
  • Figure-05: United States - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-06: United States - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-07: United States - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-08: United States - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-09: United States - Type 1 Insulin Pump User (Thousand), 2017 - 2021
  • Figure-10: United States - Forecast for Type 1 Insulin Pump User (Thousand), 2022 - 2027
  • Figure-11: United States - Type 2 Insulin Pump User (Thousand), 2017 - 2021
  • Figure-12: United States - Forecast for Type 2 Insulin Pump User (Thousand), 2022 - 2027
  • Figure-13: United States - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-14: United States - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-15: United States - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-16: United States - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-17: United Kingdom - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-18: United Kingdom - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-19: United Kingdom - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-20: United Kingdom - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-21: United Kingdom - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-22: United Kingdom - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-23: United Kingdom - Type 2 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-24: United Kingdom - Forecast for Type 2 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-25: United Kingdom - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-26: United Kingdom - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-27: United Kingdom - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-28: United Kingdom - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-29: Israel - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-30: Israel - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-31: Israel - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-32: Israel - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-33: Israel - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-34: Israel - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-35: Israel - Type 2 Insulin Pump Users (Number), 2017 - 2021
  • Figure-36: Israel - Forecast for Type 2 Insulin Pump Users (Number), 2022 - 2027
  • Figure-37: Israel - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-38: Israel - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-39: Israel - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-40: Israel - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-41: Germany - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-42: Germany - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-43: Germany - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-44: Germany - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-45: Germany - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-46: Germany - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-47: Germany - Type 2 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-48: Germany - Forecast for Type 2 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-49: Germany - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-50: Germany - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-51: Germany - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-52: Germany - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-53: Netherlands - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-54: Netherlands - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-55: Netherlands - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-56: Netherlands - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-57: Netherlands - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-58: Netherlands - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-59: Netherlands - Type 2 Insulin Pump Users (Number), 2017 - 2021
  • Figure-60: Netherlands - Forecast for Type 2 Insulin Pump Users (Number), 2022 - 2027
  • Figure-61: Netherlands - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-62: Netherlands - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-63: Netherlands - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-64: Netherlands - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-65: Sweden - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-66: Sweden - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-67: Sweden - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-68: Sweden - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-69: Sweden - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-70: Sweden - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-71: Sweden - Type 2 Insulin Pump Users (Number), 2017 - 2021
  • Figure-72: Sweden - Forecast for Type 2 Insulin Pump Users (Number), 2022 - 2027
  • Figure-73: Sweden - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-74: Sweden - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-75: Sweden - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-76: Sweden - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-77: France - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-78: France - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-79: France - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-80: France - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-81: France - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-82: France - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-83: France - Type 2 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-84: France - Forecast for Type 2 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-85: France - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-86: France - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-87: France - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-88: France - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-89: Switzerland - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-90: Switzerland - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-91: Switzerland - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-92: Switzerland - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-93: Switzerland - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-94: Switzerland - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-95: Switzerland - Type 2 Insulin Pump Users (Number), 2017 - 2021
  • Figure-96: Switzerland - Forecast for Type 2 Insulin Pump Users (Number), 2022 - 2027
  • Figure-97: Switzerland - Type 1 Switzerland Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-98: Switzerland - Forecast for Type 1 Switzerland Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-99: Switzerland - Type 2 Switzerland Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-100: Switzerland - Forecast for Type 2 Switzerland Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-101: Australia - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-102: Australia - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-103: Australia - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-104: Australia - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-105: Australia - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-106: Australia - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-107: Australia - Type 2 Insulin Pump Users (Number), 2017 - 2021
  • Figure-108: Australia - Forecast for Type 2 Insulin Pump Users (Number), 2022 - 2027
  • Figure-109: Australia - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-110: Australia - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-111: Australia - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-112: Australia - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-113: Japan - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-114: Japan - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-115: Japan - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-116: Japan - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-117: Japan - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-118: Japan - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-119: Japan - Type 2 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-120: Japan - Forecast for Type 2 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-121: Japan - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-122: Japan - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-123: Japan - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-124: Japan - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-125: Canada - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-126: Canada - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-127: Canada - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-128: Canada - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-129: Canada - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-130: Canada - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-131: Canada - Type 2 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-132: Canada - Forecast for Type 2 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-133: Canada - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-134: Canada - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-135: Canada - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-136: Canada - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-137: Kuwait - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-138: Kuwait - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-139: Kuwait - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-140: Kuwait - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-141: Kuwait - Type 1 Insulin Pump Users (Number), 2017 - 2021
  • Figure-142: Kuwait - Forecast for Type 1 Insulin Pump Users (Number), 2022 - 2027
  • Figure-143: Kuwait - Type 2 Insulin Pump Users (Number), 2017 - 2021
  • Figure-144: Kuwait - Forecast for Type 2 Insulin Pump Users (Number), 2022 - 2027
  • Figure-145: Kuwait - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-146: Kuwait - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-147: Kuwait - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-148: Kuwait - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-149: Saudi Arabia - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-150: Saudi Arabia - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-151: Saudi Arabia - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-152: Saudi Arabia - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-153: Saudi Arabia - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-154: Saudi Arabia - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-155: Saudi Arabia - Type 2 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-156: Saudi Arabia - Forecast for Type 2 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-157: Saudi Arabia - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-158: Saudi Arabia - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-159: Saudi Arabia - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-160: Saudi Arabia - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-161: Italy - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-162: Italy - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-163: Italy - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-164: Italy - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-165: Italy - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-166: Italy - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-167: Italy - Type 2 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-168: Italy - Forecast for Type 2 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-169: Italy - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-170: Italy - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-171: Italy - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-172: Italy - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-173: Spain - Type 1 Diabetes Population (Thousand), 2017 - 2021
  • Figure-174: Spain - Forecast for Type 1 Diabetes Population (Thousand), 2022 - 2027
  • Figure-175: Spain - Type 2 Diabetes Population (Thousand), 2017 - 2021
  • Figure-176: Spain - Forecast for Type 2 Diabetes Population (Thousand), 2022 - 2027
  • Figure-177: Spain - Type 1 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-178: Spain - Forecast for Type 1 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-179: Spain - Type 2 Insulin Pump Users (Thousand), 2017 - 2021
  • Figure-180: Spain - Forecast for Type 2 Insulin Pump Users (Thousand), 2022 - 2027
  • Figure-181: Spain - Type 1 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-182: Spain - Forecast for Type 1 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-183: Spain - Type 2 Insulin Pump Market (Million US$), 2017 - 2021
  • Figure-184: Spain - Forecast for Type 2 Insulin Pump Market (Million US$), 2022 - 2027
  • Figure-185: Medtronic - Global Revenue Market (Million US$), 2017 - 2021
  • Figure-186: Medtronic - Forecast for Global Revenue Market (Million US$), 2022 - 2027
  • Figure-187: Insulet Corporation - Global Revenue Market (Million US$), 2017 - 2021
  • Figure-188: Insulet Corporation - Forecast for Global Revenue Market (Million US$), 2022 - 2027
  • Figure-189: Tandem Diabetes Care - Global Revenue Market (Million US$), 2017 - 2021
  • Figure-190: Tandem Diabetes Care - Forecast for Global Revenue Market (Million US$), 2022 - 2027
  • Figure-191: Roche - Global Revenue Market (Million US$), 2017 - 2021
  • Figure-192: Roche - Forecast for Global Revenue Market (Million US$), 2022 - 2027

List of Tables

  • Table-01: Global - Insulin Pump Market Share by Country (Percentage), 2017 - 2021
  • Table-02: Global - Forecast for Insulin Pump Market Share by Country (Percentage), 2022 - 2027
  • Table-03: Global - Insulin Pump Volume Share by Country (Percentage), 2017 - 2021
  • Table-04: Global - Forecast for Insulin Pump Volume Share by Country (Percentage), 2022 - 2027